Clinical Trial

Left Bundle Branch Area Pacing in Patients With Heart Failure

Study acronym: LBBAPHF
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 5, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The relevance of Left Bundle Branch Pacing (LBBP) lies in its potential as a promising treatment option for patients with heart failure and left bundle branch block. LBBP aims to restore the normal physiological activation of the heart by delivering electrical impulses to the anatomical area of the left bundle branch, which may lead to more effective and synchronized ventricular contractions. Compared to traditional cardiac resynchronization therapy (CRT), this can result in a more physiological correction of dyssynchrony, improvement in left ventricular pump function, reduction in left ventricular volumes, and a decrease in mitral regurgitation. A crucial criterion is the reduction of heart failure symptoms and the enhancement of the patients quality of life.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06488989
Lead Sponsor National Research Center for Cardiac Surgery, Kazakhstan
Conditions Heart Failure With Reduced Ejection Fraction, Left Bundle Branch Area Pacing, Heart Failure, Cardiac Resynchronization Therapy, Cardiac Resynchronization Therapy Devices, Conduction System Pacing, Left Bundle-Branch Block
Enrollment 50 participants
Start Date 2024-06-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-05